Evolution Wealth Advisors, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
Evolution Wealth Advisors, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2021$6,000
-62.5%
154
-60.1%
0.00%
-66.7%
Q2 2021$16,000
-11.1%
386
-7.0%
0.00%
-25.0%
Q1 2021$18,000
-18.2%
415
-7.2%
0.00%
-20.0%
Q4 2020$22,000
+37.5%
447
+16.7%
0.01%
+25.0%
Q3 2020$16,000
+77.8%
383
+101.6%
0.00%
+33.3%
Q2 2020$9,0001900.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 3,391,754$134,04264.43%
Vantage Consulting Group Inc 1,022,194$35,462,04720.94%
Indie Asset Partners, LLC 462,000$18,258,24020.01%
Silicon Valley Community Foundation 1,032,320$40,797,2867.84%
Overbrook Management Corp 609,352$24,081,5917.00%
Renaissance Capital LLC 137,462$5,432,4984.24%
Geo Capital Gestora de Recursos Ltd 124,090$4,9043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,974,625$78,037,1803.28%
Lagoda Investment Management, L.P. 119,080$4,706,0423.18%
VIKING GLOBAL INVESTORS LP 10,008,511$395,536,3551.98%
View complete list of ROYALTY PHARMA PLC shareholders